Puzo Michael J Gilead Sciences, Inc. Transaction History

Puzo Michael J

$355 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $190,502 - $216,034	2,600 New	2,600 $210,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $3,800 - $4,335	-50 Reduced 1.89%	2,600 $200,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $3,865 - $4,404	-50 Reduced 1.85%	2,650 $219,000
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $168,264 - $241,569	2,700 New	2,700 $231,000
Q1 2022 May 17, 2022	SELL	$57.92 - $72.58 $173,760 - $217,740	-3,000 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $88,858 - $97,089	-1,400 Reduced 31.82%	3,000 $207,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $5,665 - $6,455	-100 Reduced 2.22%	4,400 $256,000
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 2.17%	4,500 $284,000
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $6,263 - $8,022	-100 Reduced 2.13%	4,600 $344,000
Q4 2019 Jan 15, 2020	SELL	$61.62 - $67.78 $52,068 - $57,274	-845 Reduced 15.24%	4,700 $305,000
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $24,748 - $27,752	-400 Reduced 6.73%	5,545 $375,000
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $3,126 - $3,502	-50 Reduced 0.83%	5,945 $387,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $569,318 - $742,916	-9,404 Reduced 61.07%	5,995 $375,000
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $399,096 - $441,873	-5,599 Reduced 26.66%	15,399 $1.19 Million
Q2 2018 Jul 30, 2018	BUY	$64.88 - $75.68 $207,745 - $242,327	3,202 Added 17.99%	20,998 $1.49 Million
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $7,284 - $8,880	-100 Reduced 0.56%	17,796 $1.34 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $145,857 - $171,216	2,050 Added 12.94%	17,896 $1.28 Million
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $1.14 Million - $1.35 Million	15,846	15,846 $1.28 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.

Account